Principal Component Analysis on Recurrent Venous Thromboembolism
Open Access
- 1 January 2019
- journal article
- research article
- Published by SAGE Publications in Clinical and Applied Thrombosis/hemostasis
Abstract
The rates of recurrent venous thromboembolism (RVTE) vary widely, and its causes still need to be elucidated. Statistical multivariate methods can be used to determine disease predictors and improve current methods for risk calculation. The objective of this study was to apply principal component analysis to a set of data containing clinical records of patients with previous venous thromboembolism and extract the main factors that predict recurrent thrombosis. Records of 39 factors including blood and lipid parameters, hereditary thrombophilia, antiphospholipid syndrome, clinical data regarding previous thrombosis and treatment, and Doppler ultrasound results were collected from 235 patients. The results showed that 13 principal components were associated with RVTE and that 18 of 39 factors are the important for the analysis. These factors include red blood cell, white blood cell, hematocrit, red cell distribution width, glucose, lipids, natural anticoagulant, creatinine, age, as well as first deep vein thrombosis data (distal/proximal, d-dimer, and time of anticoagulation). The results demonstrated that simple clinical parameters easy to be collected can be used to predict rates of recurrence and to develop new clinical decision support systems to predict the rates of RVTE.Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2016/14172-6)
This publication has 70 references indexed in Scilit:
- Apixaban for Extended Treatment of Venous ThromboembolismThe New England Journal of Medicine, 2013
- Hematocrit and the Risk of Recurrent Venous Thrombosis: A Prospective Cohort StudyPLOS ONE, 2012
- Predicting the risk of venous thromboembolism recurrenceAmerican Journal of Hematology, 2012
- Clinical scores to predict recurrence risk of venous thromboembolismThrombosis and Haemostasis, 2012
- A local increase in red blood cell aggregation can trigger deep vein thrombosis: evidence based on quantitative cellular ultrasound imagingJournal of Thrombosis and Haemostasis, 2010
- A Multiscale Model of Venous Thrombus Formation with Surface-Mediated Control of Blood Coagulation CascadeBiophysical Journal, 2010
- Hematocrit and risk of venous thromboembolism in a general population. The Tromso studyHaematologica, 2009
- Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in womenJournal of Thrombosis and Haemostasis, 2009
- Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapyCMAJ : Canadian Medical Association Journal, 2008
- Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous ThrombosisThe New England Journal of Medicine, 1979